Actively Recruiting

Age: 18Years - 100Years
All Genders
Healthy Volunteers
NCT04993482

24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients

Led by University Hospital, Ghent · Updated on 2023-12-08

248

Participants Needed

1

Research Sites

274 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Ghent

Lead Sponsor

U

University Ghent

Collaborating Sponsor

AI-Summary

What this Trial Is About

A healthy lifestyle has proved beneficial health effects in managing type 2 diabetes mellitus (T2DM). Important lifestyle behaviors, i.e. sleep, sedentary time (SB), and physical activity (PA) subdivided into light physical activity (LPA) and moderate to vigorous physical activity (MVPA), have shown an impact on T2DM disease-specific characteristics (e.g. glycemic control). However, these behaviors have often been investigated separately. Therefore, a recent shift in research emphasizes the importance of considering these behaviors as part of a 24-hour day. Since T2DM patients can benefit from an optimal 24-hour composition as part of a healthy lifestyle, it may be interesting to investigate the 24-hour movement composition among these T2DM patients over time. Moreover, exploring associations with different personal determinants, environmental determinants, and cardiometabolic markers will provide meaningful insights in developing recommendations and creating an intervention.

CONDITIONS

Official Title

24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients

Who Can Participate

Age: 18Years - 100Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged >18 years old
  • Diagnosed with type 2 diabetes mellitus by a physician or have an HbA1C above 6.5%
  • Adults aged >18 years old (control participants)
Not Eligible

You will not qualify if you...

  • Diagnosed with type 1 diabetes mellitus (T1DM)
  • Diagnosed with pregnancy diabetes
  • Diagnosed with latent autoimmune diabetes in adults (LADA)
  • Physical disabilities that obstruct normal physical activity patterns (e.g., amputations, paralysis)
  • Cognitive disabilities that obstruct daily functioning (e.g., dementia, psychological disorders)
  • Other conditions affecting normal physical activity patterns (e.g., heart failure NYHA class 3 and 4, chronic respiratory diseases COPD stage 4, end stage nonalcoholic fatty liver disease, end stage renal failure, cancer, hospitalized)
  • Pregnancy or pregnancy less than 1 year ago
  • Participating in a physical activity intervention
  • Diagnosed with type 2 diabetes mellitus (control participants)
  • Diagnosed with type 1 diabetes mellitus (control participants)
  • Diagnosed with pregnancy diabetes (control participants)
  • Diagnosed with latent autoimmune diabetes in adults (LADA) (control participants)
  • Physical disabilities that obstruct normal physical activity patterns (control participants)
  • Cognitive disabilities that obstruct daily functioning (control participants)
  • Other conditions affecting normal physical activity patterns (control participants)
  • Pregnancy or pregnancy less than 1 year ago (control participants)
  • Participating in a physical activity intervention (control participants)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ghent University Hospital, Dept. of Endocrinology

Ghent, Belgium, 9000

Actively Recruiting

Loading map...

Research Team

I

Iris Willems, PhD student

CONTACT

M

Marieke De Craemer, Professor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here